{"name":"Aesculap AG","slug":"aesculap-ag","ticker":"","exchange":"","domain":"aesculap.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Miconazole Nitrate 2%","genericName":"Miconazole Nitrate 2%","slug":"miconazole-nitrate-2","indication":"Topical fungal infections (dermatophytosis, candidiasis, tinea pedis, tinea corporis, tinea cruris)","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"NOVOCART 3D","genericName":"NOVOCART 3D","slug":"novocart-3d","indication":"Articular cartilage defects of the knee","status":"phase_3"}]}],"pipeline":[{"name":"Miconazole Nitrate 2%","genericName":"Miconazole Nitrate 2%","slug":"miconazole-nitrate-2","phase":"marketed","mechanism":"Miconazole nitrate disrupts fungal cell membrane integrity by inhibiting ergosterol synthesis, leading to cell death.","indications":["Topical fungal infections (dermatophytosis, candidiasis, tinea pedis, tinea corporis, tinea cruris)","Pityriasis versicolor"],"catalyst":""},{"name":"NOVOCART 3D","genericName":"NOVOCART 3D","slug":"novocart-3d","phase":"phase_3","mechanism":"NOVOCART 3D is an autologous engineered cartilage construct that regenerates damaged articular cartilage by combining patient's own cells with a 3D scaffold.","indications":["Articular cartilage defects of the knee"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}